Merida Biosciences

Biotech · Cambridge, MA · Founded 2022 · Privately Held (backing)

Developer of targeted immunotherapies designed for the treatment of autoimmune and allergic diseases. Merida Biosciences is based in Cambridge, MA and was founded in 2022. It was valued at $228 million at its early-stage round in Apr 2025, the last priced event on record. It has raised $154 million across 1 recorded round; the latest was a $121 million Series A in Apr 2025.

PMV mark · valuation

$228.0M

Oct 2026

Priced at

its early-stage round

Apr 2025

Total raised

$154.0M

Last round

Series A

Apr 2025

Leadership

Adam Townsend
President & Chief Executive Officer
Allison Dorval
Chief Financial Officer
Dario Gutierrez
Founder & Chief Scientific Officer
Dodzie Sogah
Chief Operating Officer
Michael Naill
SVP, Process & Product Development

+ 3 more people (board, observers, advisors) · free account shows everyone

Membership and data by Private Market View

Who runs Merida Biosciences

8 people are listed on the Merida Biosciences team: 6 executives and 2 advisors and observers, including Adam Townsend (President) and Dario Gutierrez (Founder).

Free account

More of Merida Biosciences with a free account

·Everyone on the team, board and advisors included
·Watch Merida Biosciences: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View